Pten haploinsufficiency accelerates formation of high-grade astrocytomas.
暂无分享,去创建一个
R. Mason | D. Burns | Hong Wu | L. Parada | Jing Chen | Dawen Zhao | Yanjiao Li | E. Lee | C. Kwon | S. Alcantara
[1] T. Shimazaki,et al. [Mammalian neural stem cells]. , 2008, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.
[2] Keara M. Lane,et al. ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice. , 2006, Cancer research.
[3] R. Henkelman,et al. High-grade glioma formation results from postnatal pten loss or mutant epidermal growth factor receptor expression in a transgenic mouse glioma model. , 2006, Cancer research.
[4] Oscar Gonzalez-Perez,et al. Origin of Oligodendrocytes in the Subventricular Zone of the Adult Brain , 2006, The Journal of Neuroscience.
[5] A. Vincent,et al. Faculty Opinions recommendation of Pten regulates neuronal arborization and social interaction in mice. , 2006 .
[6] Wei Zhang,et al. Pten Regulates Neuronal Arborization and Social Interaction in Mice , 2006, Neuron.
[7] S. Baker,et al. Neuron‐specific enolase‐cre mouse line with cre activity in specific neuronal populations , 2006, Genesis.
[8] Thomas D. Wu,et al. Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.
[9] Junying Yuan,et al. Pten deficiency activates distinct downstream signaling pathways in a tissue-specific manner. , 2006, Cancer research.
[10] Dawen Zhao,et al. Early inactivation of p53 tumor suppressor gene cooperating with NF1 loss induces malignant astrocytoma. , 2005, Cancer cell.
[11] P. Pandolfi,et al. Somatic induction of Pten loss in a preclinical astrocytoma model reveals major roles in disease progression and avenues for target discovery and validation. , 2005, Cancer research.
[12] P. Kleihues,et al. Population-based studies on incidence, survival rates, and genetic alterations in astrocytic and oligodendroglial gliomas. , 2005, Journal of neuropathology and experimental neurology.
[13] B. Luikart,et al. TrkB Has a Cell-Autonomous Role in the Establishment of Hippocampal Schaffer Collateral Synapses , 2005, The Journal of Neuroscience.
[14] P. Pandolfi,et al. mTOR promotes survival and astrocytic characteristics induced by Pten/AKT signaling in glioblastoma. , 2005, Neoplasia.
[15] E. Holland,et al. Cell type-specific tumor suppression by Ink4a and Arf in Kras-induced mouse gliomagenesis. , 2005, Cancer research.
[16] Martin J. van den Bent,et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. , 2005, The New England journal of medicine.
[17] D. Gutmann,et al. Pten Loss Causes Hypertrophy and Increased Proliferation of Astrocytes In vivo , 2004, Cancer Research.
[18] S. Hilsenbeck,et al. Somatic Mutation of p53 Leads to Estrogen Receptor α-Positive and -Negative Mouse Mammary Tumors with High Frequency of Metastasis , 2004, Cancer Research.
[19] Daniel H. Geschwind,et al. Cancerous stem cells can arise from pediatric brain tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[20] Cynthia Hawkins,et al. Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.
[21] Hong Wu,et al. PTEN tumor suppressor regulates p53 protein levels and activity through phosphatase-dependent and -independent mechanisms. , 2003, Cancer cell.
[22] G. Fuller,et al. Ink4a-Arf loss cooperates with KRas activation in astrocytes and neural progenitors to generate glioblastomas of various morphologies depending on activated Akt. , 2002, Cancer research.
[23] D. Steindler,et al. Human cortical glial tumors contain neural stem‐like cells expressing astroglial and neuronal markers in vitro , 2002, Glia.
[24] L. Parada,et al. The Molecular and Genetic Basis of Neurological Tumours , 2002, Nature Reviews Cancer.
[25] Tao Sun,et al. Common Developmental Requirement for Olig Function Indicates a Motor Neuron/Oligodendrocyte Connection , 2002, Cell.
[26] P. Pandolfi,et al. Astrocyte inactivation of the pRb pathway predisposes mice to malignant astrocytoma development that is accelerated by PTEN mutation. , 2002, Cancer cell.
[27] A. Trumpp,et al. Negative Regulation of Neural Stem/Progenitor Cell Proliferation by the Pten Tumor Suppressor Gene in Vivo , 2001, Science.
[28] K. Willecke,et al. hGFAP‐cre transgenic mice for manipulation of glial and neuronal function in vivo , 2001, Genesis.
[29] R. DePinho,et al. Malignant glioma: genetics and biology of a grave matter. , 2001, Genes & development.
[30] D. Gutmann,et al. Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas. , 2001, Cancer research.
[31] Arturo Alvarez-Buylla,et al. A unified hypothesis on the lineage of neural stem cells , 2001, Nature Reviews Neuroscience.
[32] L. Parada,et al. Neurofibromin, a tumor suppressor in the nervous system. , 2001, Experimental cell research.
[33] Karlyne M. Reilly,et al. Nf1;Trp53 mutant mice develop glioblastoma with evidence of strain-specific effects , 2000, Nature Genetics.
[34] Eric C. Holland,et al. Combined activation of Ras and Akt in neural progenitors induces glioblastoma formation in mice , 2000, Nature Genetics.
[35] Webster K. Cavenee,et al. Pathology and genetics of tumours of the nervous system. , 2000 .
[36] L. Schriml,et al. Mutational spectra of PTEN/MMAC1 gene: a tumor suppressor with lipid phosphatase activity. , 1999, Journal of the National Cancer Institute.
[37] Daniel A. Lim,et al. Subventricular Zone Astrocytes Are Neural Stem Cells in the Adult Mammalian Brain , 1999, Cell.
[38] C. Walsh,et al. Doublecortin Is a Microtubule-Associated Protein and Is Expressed Widely by Migrating Neurons , 1999, Neuron.
[39] L. Cantley,et al. New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[40] C. Cordon-Cardo,et al. Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[41] T. Mak,et al. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice , 1998, Current Biology.
[42] José Luis de la Pompa,et al. Negative Regulation of PKB/Akt-Dependent Cell Survival by the Tumor Suppressor PTEN , 1998, Cell.
[43] Carlos Cordon-Cardo,et al. Pten is essential for embryonic development and tumour suppression , 1998, Nature Genetics.
[44] Tomohiko Maehama,et al. The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate* , 1998, The Journal of Biological Chemistry.
[45] R. Zidovetzki,et al. Up-regulation of the cAMP/PKA pathway inhibits proliferation, induces differentiation, and leads to apoptosis in malignant gliomas. , 1998, Laboratory investigation; a journal of technical methods and pathology.
[46] J. Gusella,et al. Rescue of a Drosophila NF1 mutant phenotype by protein kinase A. , 1997, Science.
[47] J. Shinoda,et al. Differential expression of Rho family GTP-binding proteins and protein kinase C isozymes during C6 glial cell differentiation. , 1997, Brain research. Molecular brain research.
[48] H. Wiley,et al. The Enhanced Tumorigenic Activity of a Mutant Epidermal Growth Factor Receptor Common in Human Cancers Is Mediated by Threshold Levels of Constitutive Tyrosine Phosphorylation and Unattenuated Signaling* , 1997, The Journal of Biological Chemistry.
[49] R. Weinberg,et al. Tumor spectrum analysis in p53-mutant mice , 1994, Current Biology.
[50] M. Izquierdo,et al. Timing of p53 mutations during astrocytoma tumorigenesis. , 1993, Human molecular genetics.